RiceBran Technologies(US:RIBT)2023-03-16 20:31Company Overview - The company is a market leader in North America for converting raw rice bran into stabilized rice bran (SRB) and high-value SRB derivative products[12]. - The company operates two specialty mills, including a rice mill in Arkansas and a grain mill in Minnesota, enhancing its production capabilities[16][36]. - The company focuses on developing, producing, and marketing specialty ingredients derived from traditional and ancient small grains, emphasizing natural, non-GMO, and organic products[144]. - The company produces stabilized rice bran (SRB) and high value-added derivative products, including RiBalance, RiSolubles, RiFiber, and ProRyza, which cater to health-conscious consumers[145]. - The company operates four production facilities, including two in California and two in the Louisiana and Arkansas delta region, with additional specialty milling facilities in Montana and Minnesota[147]. - The company has one reporting unit and one operating segment, which is specialty ingredients, reflecting the integrated nature of its products and production facilities[148]. Financial Performance - Revenues for 2022 were $41.6 million, an increase of $10.5 million or 33.7% compared to $31.1 million in 2021, driven by strong growth in MGI and Golden Ridge milling operations[105]. - Total revenues for 2022 were $41.617 million, a 33.6% increase from $31.131 million in 2021[133]. - The company reported a net loss of $7.858 million in 2022, compared to a net loss of $8.949 million in 2021, indicating a reduction in losses[133]. - Operating loss was $7.2 million in 2022, an improvement from an operating loss of $10.6 million in 2021, due to reduced gross losses and improved SG&A[109]. - Cash and equivalents as of December 31, 2022, were $3.9 million, a decline of $1.9 million from $5.8 million on December 31, 2021[111]. - Cash used in operating activities in 2022 was $3.9 million, compared to $4.2 million in 2021, primarily driven by increased net losses[111]. - The company recognized a gain of $0.1 million in 2022 on the involuntary conversion of assets related to hurricane damage insurance claims[108]. - The company expects improved operating cash flows in 2023 due to the transition of sourcing and selling activities for its Arkansas mill and capital investments in its Minnesota mill[140]. - The transition of the Arkansas mill to a service provider resulted in its first positive quarterly contribution to operating cash flows in Q4 2022[140]. - The Minnesota mill saw a significant increase in sales and profit contribution in Q4 2022 due to additional capacity coming online[140]. Customer Concentration and Market Demand - In 2022, three customers accounted for 29.2% of the company's revenues, indicating a need for diversification of the customer base[39]. - The company anticipates further adoption of its ingredients by food companies due to increasing consumer demand for minimally processed, non-GMO, gluten-free ingredients[38]. - The company relies on a limited number of customers, with significant credit risk associated with outstanding accounts receivable, which could adversely affect operations[68]. - In 2022, three customers accounted for 29.2% of revenues, and the top ten customers represented 54.4% of revenues, highlighting a significant customer concentration risk[66]. Operational Challenges - The company has experienced increased competition, which negatively impacted financial results in 2022 and is expected to continue affecting performance[47]. - The company must increase marketing efforts to raise awareness of rice bran products, requiring substantial management and financial resources[70]. - The company’s production capacity is currently limited, and any dramatic increase in demand may require additional investment and time to scale operations[71]. - The company faces inflationary pressures that could increase operating expenses and affect its ability to service debt, potentially impacting profitability[60]. Compliance and Regulatory Issues - The company is committed to compliance with the FDA Food Safety Modernization Act (FSMA) and maintains SQF certification at all facilities[44]. - The company is subject to extensive laws and regulations, including those from the FDA and USDA, which could lead to significant compliance costs or loss of sales revenues if not adhered to[74]. Financial Liabilities and Risks - The company reported a net cash used in operating activities of $3.9 million in 2022 and $4.2 million in 2021, indicating ongoing financial challenges[54]. - As of December 31, 2022, the company has incurred an accumulated deficit exceeding $316 million, raising concerns about future profitability and financial viability[55]. - The company has a $7.0 million credit facility under a factoring agreement, which is secured by personal property assets, posing a risk if repayment is demanded[57]. - The company has $2.8 million remaining under an at-the-market offering program with an aggregate offering price of up to $6.0 million[113]. - Total liabilities increased to $14.524 million in 2022 from $12.818 million in 2021, reflecting a rise in current liabilities[131]. - The company has limited insurance coverage for many business risks, which could materially affect its financial condition in the event of significant uninsured claims[78]. Employee and Management Considerations - The company employs 94 individuals as of December 31, 2022, and focuses on creating a dynamic and inclusive work environment[49]. - The company is dependent on key employees, including top management, and may face challenges in attracting and retaining talent due to stock price volatility[81]. Stock and Equity Information - As of March 16, 2023, there are 6,384,334 shares of common stock outstanding, with an additional 2,349,083 shares issuable upon exercise of stock options and warrants, indicating a significant equity overhang[85]. - The company must maintain a minimum of $2.5 million in shareholders' equity and a minimum common stock bid price of $1.00 to comply with NASDAQ listing requirements[87]. - The company has never declared or paid any cash dividends on its common stock and plans to retain future earnings for business expansion[102]. Miscellaneous - The company is not currently involved in any material litigation, but may face legal proceedings in the ordinary course of business[97]. - The company’s stock price has experienced significant volatility, which may continue to affect investor perception and shareholder litigation risks[83].